Clinical Trial Update: A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of sintilimab and ramucirumab with chemotherapy as first-line treatment for gastric cancer with liver metastasis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Ramucirumab (ramucirumab)
• Sintilimab (sintilimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Stomach Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING